 | • レポートコード：GIR201115125 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、エビ病診断の世界市場を調査対象にし、エビ病診断の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（WSSV（白斑症候群ウイルス）、TSV（タウラ症候群ウイルス）、YHV / GAV（黄頭/鰓関連ウイルス）、IHHNV（伝染性皮下造血器ウイルス）、HPV（肝膵臓パルボウイルス）、MBV（モノドンバキュロウイルス）、IMNV（伝染性筋壊死ウイルス）、NHP-B（壊死性肝膵炎細菌）、MoV（ムーリリアンウイルス）、早期死亡症候群（EMS））、用途別分析（水産、養殖研究所、海洋研究所、教育・研究機関、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：HiMedia Laboratories、AquaBounty Technologies, Inc、FUJIKURA KASEI CO., LTD、Speedy Assay Sdn Bhd、Lab - Ind Resource Sdn Bhd、REAGEN LLC、SUREBIO、Thermo Fisher Scientific、GeneReach Biotechnology Corp、pop bio、Auro Biotechnologies ・企業別売上、市場シェア ・エビ病診断の地域別市場分析 ・エビ病診断の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・エビ病診断のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・エビ病診断のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・エビ病診断の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・エビ病診断の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・エビ病診断の種類別市場規模2015-2020：WSSV（白斑症候群ウイルス）、TSV（タウラ症候群ウイルス）、YHV / GAV（黄頭/鰓関連ウイルス）、IHHNV（伝染性皮下造血器ウイルス）、HPV（肝膵臓パルボウイルス）、MBV（モノドンバキュロウイルス）、IMNV（伝染性筋壊死ウイルス）、NHP-B（壊死性肝膵炎細菌）、MoV（ムーリリアンウイルス）、早期死亡症候群（EMS） ・エビ病診断の用途別市場規模2015-2020：水産、養殖研究所、海洋研究所、教育・研究機関、その他 ・エビ病診断の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Shrimps Disease Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Shrimps Disease Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Shrimps Disease Diagnostic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Shrimps Disease Diagnostic market has been segmented into:
WSSV (White Spot Syndrome Virus)
TSV (Taura Syndrome Virus)
YHV/GAV (Yellow Head/Gill Associated Virus)
IHHNV (Infectious Hypodermal and Hematopoietic Virus)
HPV (Hepatopancreatic Parvovirus)
MBV (Monodon Baculovirus)
IMNV (Infectious Myonecrosis Virus)
NHP-B (Necrotising Hepatopancreatitis Bacteria)
MoV (Mourilyan Virus)
Early Mortality Syndrome (EMS)
By Application, Shrimps Disease Diagnostic has been segmented into:
Fisheries
Aquaculture Laboratories
Marine Laboratories
Education and Research Institutes
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Shrimps Disease Diagnostic market presented in the report. This section sheds light on the sales growth of different regional and country-level Shrimps Disease Diagnostic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Shrimps Disease Diagnostic market.
The report offers in-depth assessment of the growth and other aspects of the Shrimps Disease Diagnostic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Shrimps Disease Diagnostic Market Share Analysis
Shrimps Disease Diagnostic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Shrimps Disease Diagnostic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Shrimps Disease Diagnostic sales, revenue and market share for each player covered in this report.
The major players covered in Shrimps Disease Diagnostic are:
HiMedia Laboratories
AquaBounty Technologies, Inc
FUJIKURA KASEI CO., LTD
Speedy Assay Sdn Bhd
Lab – Ind Resource Sdn Bhd
REAGEN LLC
SUREBIO
Thermo Fisher Scientific
GeneReach Biotechnology Corp
pop bio
Auro Biotechnologies
Table of Contents
1 Shrimps Disease Diagnostic Market Overview
1.1 Product Overview and Scope of Shrimps Disease Diagnostic
1.2 Classification of Shrimps Disease Diagnostic by Type
1.2.1 Global Shrimps Disease Diagnostic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Shrimps Disease Diagnostic Revenue Market Share by Type in 2019
1.2.3 WSSV (White Spot Syndrome Virus)
1.2.4 TSV (Taura Syndrome Virus)
1.2.5 YHV/GAV (Yellow Head/Gill Associated Virus)
1.2.6 IHHNV (Infectious Hypodermal and Hematopoietic Virus)
1.2.7 HPV (Hepatopancreatic Parvovirus)
1.2.8 MBV (Monodon Baculovirus)
1.2.9 IMNV (Infectious Myonecrosis Virus)
1.2.10 NHP-B (Necrotising Hepatopancreatitis Bacteria)
1.2.11 MoV (Mourilyan Virus)
1.2.12 Early Mortality Syndrome (EMS)
1.3 Global Shrimps Disease Diagnostic Market by Application
1.3.1 Overview: Global Shrimps Disease Diagnostic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Fisheries
1.3.3 Aquaculture Laboratories
1.3.4 Marine Laboratories
1.3.5 Education and Research Institutes
1.3.6 Others
1.4 Global Shrimps Disease Diagnostic Market by Regions
1.4.1 Global Shrimps Disease Diagnostic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Shrimps Disease Diagnostic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Shrimps Disease Diagnostic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Shrimps Disease Diagnostic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Shrimps Disease Diagnostic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Shrimps Disease Diagnostic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Shrimps Disease Diagnostic Status and Prospect (2015-2025)
2 Company Profiles
2.1 HiMedia Laboratories
2.1.1 HiMedia Laboratories Details
2.1.2 HiMedia Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 HiMedia Laboratories SWOT Analysis
2.1.4 HiMedia Laboratories Product and Services
2.1.5 HiMedia Laboratories Shrimps Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.2 AquaBounty Technologies, Inc
2.2.1 AquaBounty Technologies, Inc Details
2.2.2 AquaBounty Technologies, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AquaBounty Technologies, Inc SWOT Analysis
2.2.4 AquaBounty Technologies, Inc Product and Services
2.2.5 AquaBounty Technologies, Inc Shrimps Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.3 FUJIKURA KASEI CO., LTD
2.3.1 FUJIKURA KASEI CO., LTD Details
2.3.2 FUJIKURA KASEI CO., LTD Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 FUJIKURA KASEI CO., LTD SWOT Analysis
2.3.4 FUJIKURA KASEI CO., LTD Product and Services
2.3.5 FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Speedy Assay Sdn Bhd
2.4.1 Speedy Assay Sdn Bhd Details
2.4.2 Speedy Assay Sdn Bhd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Speedy Assay Sdn Bhd SWOT Analysis
2.4.4 Speedy Assay Sdn Bhd Product and Services
2.4.5 Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.5 Lab – Ind Resource Sdn Bhd
2.5.1 Lab – Ind Resource Sdn Bhd Details
2.5.2 Lab – Ind Resource Sdn Bhd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Lab – Ind Resource Sdn Bhd SWOT Analysis
2.5.4 Lab – Ind Resource Sdn Bhd Product and Services
2.5.5 Lab – Ind Resource Sdn Bhd Shrimps Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.6 REAGEN LLC
2.6.1 REAGEN LLC Details
2.6.2 REAGEN LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 REAGEN LLC SWOT Analysis
2.6.4 REAGEN LLC Product and Services
2.6.5 REAGEN LLC Shrimps Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.7 SUREBIO
2.7.1 SUREBIO Details
2.7.2 SUREBIO Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 SUREBIO SWOT Analysis
2.7.4 SUREBIO Product and Services
2.7.5 SUREBIO Shrimps Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Thermo Fisher Scientific
2.8.1 Thermo Fisher Scientific Details
2.8.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Thermo Fisher Scientific SWOT Analysis
2.8.4 Thermo Fisher Scientific Product and Services
2.8.5 Thermo Fisher Scientific Shrimps Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.9 GeneReach Biotechnology Corp
2.9.1 GeneReach Biotechnology Corp Details
2.9.2 GeneReach Biotechnology Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GeneReach Biotechnology Corp SWOT Analysis
2.9.4 GeneReach Biotechnology Corp Product and Services
2.9.5 GeneReach Biotechnology Corp Shrimps Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.10 pop bio
2.10.1 pop bio Details
2.10.2 pop bio Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 pop bio SWOT Analysis
2.10.4 pop bio Product and Services
2.10.5 pop bio Shrimps Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.11 Auro Biotechnologies
2.11.1 Auro Biotechnologies Details
2.11.2 Auro Biotechnologies Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Auro Biotechnologies SWOT Analysis
2.11.4 Auro Biotechnologies Product and Services
2.11.5 Auro Biotechnologies Shrimps Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Shrimps Disease Diagnostic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Shrimps Disease Diagnostic Players Market Share
3.2.2 Top 10 Shrimps Disease Diagnostic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Shrimps Disease Diagnostic Revenue and Market Share by Regions
4.2 North America Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
4.3 Europe Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
4.5 South America Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
5 North America Shrimps Disease Diagnostic Revenue by Countries
5.1 North America Shrimps Disease Diagnostic Revenue by Countries (2015-2020)
5.2 USA Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
5.3 Canada Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
5.4 Mexico Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
6 Europe Shrimps Disease Diagnostic Revenue by Countries
6.1 Europe Shrimps Disease Diagnostic Revenue by Countries (2015-2020)
6.2 Germany Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
6.3 UK Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
6.4 France Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
6.5 Russia Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
6.6 Italy Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Shrimps Disease Diagnostic Revenue by Countries
7.1 Asia-Pacific Shrimps Disease Diagnostic Revenue by Countries (2015-2020)
7.2 China Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
7.3 Japan Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
7.4 Korea Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
7.5 India Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
8 South America Shrimps Disease Diagnostic Revenue by Countries
8.1 South America Shrimps Disease Diagnostic Revenue by Countries (2015-2020)
8.2 Brazil Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
8.3 Argentina Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Shrimps Disease Diagnostic by Countries
9.1 Middle East & Africa Shrimps Disease Diagnostic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
9.3 UAE Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
9.4 Egypt Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
9.5 South Africa Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Shrimps Disease Diagnostic Revenue and Market Share by Type (2015-2020)
10.2 Global Shrimps Disease Diagnostic Market Forecast by Type (2019-2024)
10.3 WSSV (White Spot Syndrome Virus) Revenue Growth Rate (2015-2025)
10.4 TSV (Taura Syndrome Virus) Revenue Growth Rate (2015-2025)
10.5 YHV/GAV (Yellow Head/Gill Associated Virus) Revenue Growth Rate (2015-2025)
10.6 IHHNV (Infectious Hypodermal and Hematopoietic Virus) Revenue Growth Rate (2015-2025)
10.7 HPV (Hepatopancreatic Parvovirus) Revenue Growth Rate (2015-2025)
10.8 MBV (Monodon Baculovirus) Revenue Growth Rate (2015-2025)
10.9 IMNV (Infectious Myonecrosis Virus) Revenue Growth Rate (2015-2025)
10.10 NHP-B (Necrotising Hepatopancreatitis Bacteria) Revenue Growth Rate (2015-2025)
10.11 MoV (Mourilyan Virus) Revenue Growth Rate (2015-2025)
10.12 Early Mortality Syndrome (EMS) Revenue Growth Rate (2015-2025)
11 Global Shrimps Disease Diagnostic Market Segment by Application
11.1 Global Shrimps Disease Diagnostic Revenue Market Share by Application (2015-2020)
11.2 Shrimps Disease Diagnostic Market Forecast by Application (2019-2024)
11.3 Fisheries Revenue Growth (2015-2020)
11.4 Aquaculture Laboratories Revenue Growth (2015-2020)
11.5 Marine Laboratories Revenue Growth (2015-2020)
11.6 Education and Research Institutes Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Shrimps Disease Diagnostic Market Size Forecast (2021-2025)
12.1 Global Shrimps Disease Diagnostic Market Size Forecast (2021-2025)
12.2 Global Shrimps Disease Diagnostic Market Forecast by Regions (2021-2025)
12.3 North America Shrimps Disease Diagnostic Revenue Market Forecast (2021-2025)
12.4 Europe Shrimps Disease Diagnostic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Shrimps Disease Diagnostic Revenue Market Forecast (2021-2025)
12.6 South America Shrimps Disease Diagnostic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Shrimps Disease Diagnostic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Shrimps Disease Diagnostic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Shrimps Disease Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Shrimps Disease Diagnostic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Shrimps Disease Diagnostic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. HiMedia Laboratories Corporate Information, Location and Competitors
Table 6. HiMedia Laboratories Shrimps Disease Diagnostic Major Business
Table 7. HiMedia Laboratories Shrimps Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 8. HiMedia Laboratories SWOT Analysis
Table 9. HiMedia Laboratories Shrimps Disease Diagnostic Product and Solutions
Table 10. HiMedia Laboratories Shrimps Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AquaBounty Technologies, Inc Corporate Information, Location and Competitors
Table 12. AquaBounty Technologies, Inc Shrimps Disease Diagnostic Major Business
Table 13. AquaBounty Technologies, Inc Shrimps Disease Diagnostic Total Revenue (USD Million) (2018-2019)
Table 14. AquaBounty Technologies, Inc SWOT Analysis
Table 15. AquaBounty Technologies, Inc Shrimps Disease Diagnostic Product and Solutions
Table 16. AquaBounty Technologies, Inc Shrimps Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. FUJIKURA KASEI CO., LTD Corporate Information, Location and Competitors
Table 18. FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Major Business
Table 19. FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 20. FUJIKURA KASEI CO., LTD SWOT Analysis
Table 21. FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Product and Solutions
Table 22. FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Speedy Assay Sdn Bhd Corporate Information, Location and Competitors
Table 24. Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Major Business
Table 25. Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 26. Speedy Assay Sdn Bhd SWOT Analysis
Table 27. Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Product and Solutions
Table 28. Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Lab - Ind Resource Sdn Bhd Corporate Information, Location and Competitors
Table 30. Lab - Ind Resource Sdn Bhd Shrimps Disease Diagnostic Major Business
Table 31. Lab - Ind Resource Sdn Bhd Shrimps Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 32. Lab - Ind Resource Sdn Bhd SWOT Analysis
Table 33. Lab - Ind Resource Sdn Bhd Shrimps Disease Diagnostic Product and Solutions
Table 34. Lab - Ind Resource Sdn Bhd Shrimps Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. REAGEN LLC Corporate Information, Location and Competitors
Table 36. REAGEN LLC Shrimps Disease Diagnostic Major Business
Table 37. REAGEN LLC Shrimps Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 38. REAGEN LLC SWOT Analysis
Table 39. REAGEN LLC Shrimps Disease Diagnostic Product and Solutions
Table 40. REAGEN LLC Shrimps Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. SUREBIO Corporate Information, Location and Competitors
Table 42. SUREBIO Shrimps Disease Diagnostic Major Business
Table 43. SUREBIO Shrimps Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 44. SUREBIO SWOT Analysis
Table 45. SUREBIO Shrimps Disease Diagnostic Product and Solutions
Table 46. SUREBIO Shrimps Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 48. Thermo Fisher Scientific Shrimps Disease Diagnostic Major Business
Table 49. Thermo Fisher Scientific Shrimps Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 50. Thermo Fisher Scientific SWOT Analysis
Table 51. Thermo Fisher Scientific Shrimps Disease Diagnostic Product and Solutions
Table 52. Thermo Fisher Scientific Shrimps Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. GeneReach Biotechnology Corp Corporate Information, Location and Competitors
Table 54. GeneReach Biotechnology Corp Shrimps Disease Diagnostic Major Business
Table 55. GeneReach Biotechnology Corp Shrimps Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 56. GeneReach Biotechnology Corp SWOT Analysis
Table 57. GeneReach Biotechnology Corp Shrimps Disease Diagnostic Product and Solutions
Table 58. GeneReach Biotechnology Corp Shrimps Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. pop bio Corporate Information, Location and Competitors
Table 60. pop bio Shrimps Disease Diagnostic Major Business
Table 61. pop bio Shrimps Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 62. pop bio SWOT Analysis
Table 63. pop bio Shrimps Disease Diagnostic Product and Solutions
Table 64. pop bio Shrimps Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Auro Biotechnologies Corporate Information, Location and Competitors
Table 66. Auro Biotechnologies Shrimps Disease Diagnostic Major Business
Table 67. Auro Biotechnologies Shrimps Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 68. Auro Biotechnologies SWOT Analysis
Table 69. Auro Biotechnologies Shrimps Disease Diagnostic Product and Solutions
Table 70. Auro Biotechnologies Shrimps Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Shrimps Disease Diagnostic Revenue (Million USD) by Players (2015-2020)
Table 72. Global Shrimps Disease Diagnostic Revenue Share by Players (2015-2020)
Table 73. Global Shrimps Disease Diagnostic Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Shrimps Disease Diagnostic Revenue Market Share by Regions (2015-2020)
Table 75. North America Shrimps Disease Diagnostic Revenue by Countries (2015-2020)
Table 76. North America Shrimps Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Table 77. Europe Shrimps Disease Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Shrimps Disease Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Shrimps Disease Diagnostic Revenue by Countries (2015-2020)
Table 80. South America Shrimps Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Shrimps Disease Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Shrimps Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Table 83. Global Shrimps Disease Diagnostic Revenue (Million USD) by Type (2015-2020)
Table 84. Global Shrimps Disease Diagnostic Revenue Share by Type (2015-2020)
Table 85. Global Shrimps Disease Diagnostic Revenue Forecast by Type (2021-2025)
Table 86. Global Shrimps Disease Diagnostic Revenue by Application (2015-2020)
Table 87. Global Shrimps Disease Diagnostic Revenue Share by Application (2015-2020)
Table 88. Global Shrimps Disease Diagnostic Revenue Forecast by Application (2021-2025)
Table 89. Global Shrimps Disease Diagnostic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Shrimps Disease Diagnostic Picture
Figure 2. Global Shrimps Disease Diagnostic Revenue Market Share by Type in 2019
Figure 3. WSSV (White Spot Syndrome Virus) Picture
Figure 4. TSV (Taura Syndrome Virus) Picture
Figure 5. YHV/GAV (Yellow Head/Gill Associated Virus) Picture
Figure 6. IHHNV (Infectious Hypodermal and Hematopoietic Virus) Picture
Figure 7. HPV (Hepatopancreatic Parvovirus) Picture
Figure 8. MBV (Monodon Baculovirus) Picture
Figure 9. IMNV (Infectious Myonecrosis Virus) Picture
Figure 10. NHP-B (Necrotising Hepatopancreatitis Bacteria) Picture
Figure 11. MoV (Mourilyan Virus) Picture
Figure 12. Early Mortality Syndrome (EMS) Picture
Figure 13. Shrimps Disease Diagnostic Revenue Market Share by Application in 2019
Figure 14. Fisheries Picture
Figure 15. Aquaculture Laboratories Picture
Figure 16. Marine Laboratories Picture
Figure 17. Education and Research Institutes Picture
Figure 18. Others Picture
Figure 19. Global Shrimps Disease Diagnostic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 20. North America Shrimps Disease Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Europe Shrimps Disease Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Asia-Pacific Shrimps Disease Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. South America Shrimps Disease Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Middle East and Africa Shrimps Disease Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 25. Global Shrimps Disease Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 26. Global Shrimps Disease Diagnostic Revenue Share by Players in 2019
Figure 27. Global Top 5 Players Shrimps Disease Diagnostic Revenue Market Share in 2019
Figure 28. Global Top 10 Players Shrimps Disease Diagnostic Revenue Market Share in 2019
Figure 29. Key Players Market Share Trend
Figure 30. Global Shrimps Disease Diagnostic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 31. Global Shrimps Disease Diagnostic Revenue Market Share by Regions (2015-2020)
Figure 32. Global Shrimps Disease Diagnostic Revenue Market Share by Regions in 2018
Figure 33. North America Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 34. Europe Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 35. Asia-Pacific Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 36. South America Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 37. Middle East and Africa Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 38. North America Shrimps Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 39. North America Shrimps Disease Diagnostic Revenue Market Share by Countries in 2019
Figure 40. USA Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 41. Canada Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 42. Mexico Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 43. Europe Shrimps Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 44. Europe Shrimps Disease Diagnostic Revenue Market Share by Countries in 2019
Figure 45. Germany Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 46. UK Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 47. France Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 48. Russia Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 49. Italy Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 50. Asia-Pacific Shrimps Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 51. Asia-Pacific Shrimps Disease Diagnostic Revenue Market Share by Countries in 2019
Figure 52. China Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 53. Japan Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 54. Korea Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 55. India Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 56. Southeast Asia Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 57. South America Shrimps Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 58. South America Shrimps Disease Diagnostic Revenue Market Share by Countries in 2019
Figure 59. Brazil Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 60. Argentina Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 61. Middle East and Africa Shrimps Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 62. Middle East and Africa Shrimps Disease Diagnostic Revenue Market Share by Countries in 2019
Figure 63. Saudi Arabia Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 64. UAE Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 65. Egypt Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 66. South Africa Shrimps Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 67. Global Shrimps Disease Diagnostic Revenue Share by Type (2015-2020)
Figure 68. Global Shrimps Disease Diagnostic Revenue Share by Type in 2019
Figure 69. Global Shrimps Disease Diagnostic Market Share Forecast by Type (2021-2025)
Figure 70. Global WSSV (White Spot Syndrome Virus) Revenue Growth Rate (2015-2020)
Figure 71. Global TSV (Taura Syndrome Virus) Revenue Growth Rate (2015-2020)
Figure 72. Global YHV/GAV (Yellow Head/Gill Associated Virus) Revenue Growth Rate (2015-2020)
Figure 73. Global IHHNV (Infectious Hypodermal and Hematopoietic Virus) Revenue Growth Rate (2015-2020)
Figure 74. Global HPV (Hepatopancreatic Parvovirus) Revenue Growth Rate (2015-2020)
Figure 75. Global MBV (Monodon Baculovirus) Revenue Growth Rate (2015-2020)
Figure 76. Global IMNV (Infectious Myonecrosis Virus) Revenue Growth Rate (2015-2020)
Figure 77. Global NHP-B (Necrotising Hepatopancreatitis Bacteria) Revenue Growth Rate (2015-2020)
Figure 78. Global MoV (Mourilyan Virus) Revenue Growth Rate (2015-2020)
Figure 79. Global Early Mortality Syndrome (EMS) Revenue Growth Rate (2015-2020)
Figure 80. Global Shrimps Disease Diagnostic Revenue Share by Application (2015-2020)
Figure 81. Global Shrimps Disease Diagnostic Revenue Share by Application in 2019
Figure 82. Global Shrimps Disease Diagnostic Market Share Forecast by Application (2021-2025)
Figure 83. Global Fisheries Revenue Growth Rate (2015-2020)
Figure 84. Global Aquaculture Laboratories Revenue Growth Rate (2015-2020)
Figure 85. Global Marine Laboratories Revenue Growth Rate (2015-2020)
Figure 86. Global Education and Research Institutes Revenue Growth Rate (2015-2020)
Figure 87. Global Others Revenue Growth Rate (2015-2020)
Figure 88. Global Shrimps Disease Diagnostic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 89. Global Shrimps Disease Diagnostic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 90. Global Shrimps Disease Diagnostic Revenue Market Share Forecast by Regions (2021-2025)
Figure 91. North America Shrimps Disease Diagnostic Revenue Market Forecast (2021-2025)
Figure 92. Europe Shrimps Disease Diagnostic Revenue Market Forecast (2021-2025)
Figure 93. Asia-Pacific Shrimps Disease Diagnostic Revenue Market Forecast (2021-2025)
Figure 94. South America Shrimps Disease Diagnostic Revenue Market Forecast (2021-2025)
Figure 95. Middle East and Africa Shrimps Disease Diagnostic Revenue Market Forecast (2021-2025)
Figure 96. Sales Channel: Direct Channel vs Indirect Channel
性感染症治療薬の世界市場 2020年 Market Overview The global Sexually Transmitted Disease Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sex…- 顧みられない熱帯病(NTD)治療の世界市場 2020年 Market Overview The global Neglected Tropical Disease Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neglect…
- アルツハイマー病治療の世界市場 2020年 Market Overview The global Alzheimer's Disease Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alzheimer's Di…
- 希少疾患診断の世界市場 2020年 Market Overview The global Rare Disease Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Rare Disease Diagnos…
- モノクローナル抗体診断試薬の世界市場 2020年 Market Overview The Monoclonal Antibody Diagnostic Reagents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…